DuPont de Nemours, Inc. DD
155.14 USD +8.62 (+5.88%)
At closeNov 10, 2026, 7:00 AM EST
154.95 -0.19 -0.12%
Pre-market · Nov 10, 7:00 AM ET
150.21 Day range 155.18
111.15 52-week range 157.98
- YTD
- +28.64%
- 1 year
- +29.93%
News
benzinga.com Jim Cramer Picks DuPont Over Xylem, Has Cold Feet on Lam Research Xylem, a water technology provider, saw its shares fall 1% to close at $100.05 on Thursday. Vertiv shares dipped 14% to settle at $176.73.
benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Raises Price Target to $173 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and raises the price target from $160 to $173.
benzinga.com Wells Fargo Maintains Overweight on DuPont de Nemours, Raises Price Target to $170 Wells Fargo analyst Abigail Eberts maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $166 to $170.
defenseworld.net DuPont (NYSE: DD) raises guidance again and adjusted EPS jumps 62% What happened DuPont de Nemours, Inc. (NYSE: DD) beat its third-quarter guidance on Nov. 3 and raised its full-year 2026 outlook again. Net sales rose 4% to $1.87 billion. Organic sales grew 5%, and…
benzinga.com UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $182 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $172 to $182.
benzinga.com Citigroup Maintains Buy on DuPont de Nemours, Raises Price Target to $176 Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $162 to $176.- benzinga.com Barclays Maintains Overweight on DuPont de Nemours, Raises Price Target to $176 Barclays analyst Aleksey Yefremov maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $156 to $176.
marketbeat.com DuPont de Nemours Q3 Earnings Call Highlights DuPont de Nemours NYSE: DD reported third-quarter 2026 results above its prior guidance, citing broad-based sales growth, productivity gains and higher margins. The company raised its full-year…
fool.com Why DuPont Stock Trounced the Market on Tuesday It delivered growth on both the top and bottom lines for the period. It topped analyst estimates for both line items.
seekingalpha.com DuPont de Nemours, Inc. (DD) Q3 2026 Earnings Call Transcript DuPont de Nemours, Inc. ( DD ) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Company Participants Ann Giancristoforo - VP of Investor Relations, Corporate FP&A, Strategic Finance Lori Koch - CEO…- benzinga.com Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Fermium Research analyst Frank Mitsch maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $154 to $160.
benzinga.com Fabrinet, EverQuote, Lattice Semiconductor, Fiserv And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed as Dow fell 200 points; Fabrinet surged 13.7% on strong results, guidance and buyback, while several small caps rallied.
benzinga.com DuPont Raises Outlook As Order Book Climbs and AI Cuts Development Time DuPont earnings beat estimates as double-digit orders, AI gains and stronger guidance offset Middle East water delays.
zacks.com DD Q3 Earnings Beat on Organic Growth, Raises 2026 Outlook DuPont beats Q3 earnings estimates on strong organic growth, raises its 2026 outlook and plans more buybacks.
zacks.com DuPont de Nemours (DD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for DuPont de Nemours (DD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key…
benzinga.com DuPont de Nemours Q3 2026 Earnings Call Transcript DuPont de Nemours (NYSE:DD) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
wsj.com DuPont Swings to a Profit and Lifts Outlook DuPont swung to a third-quarter profit of $123 million, or 91 cents a share, from a loss of $123 million, or 88 cents a share, a year earlier.
reuters.com DuPont raises full-year profit forecasts on strong healthcare, aerospace demand DuPont raises full-year profit forecasts on strong healthcare, aerospace demand
benzinga.com DuPont de Nemours Sees Q4 Adj EPS $1.90-$1.95 vs $1.87 Est; Sees Sales $1.825B vs $1.824B Est DuPont de Nemours (NYSE:DD) is looking for Q4 Adj EPS of $1.90-$1.95 vs $1.87 analyst estimate. sees sales of $1.825 billion vs $1.824 billion analyst estimate.
benzinga.com DuPont de Nemours Raises FY2026 Adj EPS Guidance from $7.17-$7.32 to $7.47-$7.52 vs $7.25 Est; Raises FY2026 Sales Guidance from $7.160B-$7.190B to $7.190B vs $7.169B Est DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.17-$7.32 to $7.47-$7.52 vs $7.25 analyst estimate. Raises FY2026 sales outlook from $7.160 billion-$7.190 billion to $7.190 billion…
benzinga.com DuPont de Nemours Q3 Adj. EPS $2.09 Beats $1.87 Estimate, Sales $1.868B Beat $1.843B Estimate DuPont de Nemours (NYSE:DD) reported quarterly earnings of $2.09 per share which beat the analyst consensus estimate of $1.87 by 11.76 percent. This is a 36.09 percent decrease over earnings of $3.27…
prnewswire.com DuPont Reports Third Quarter 2026 Results Exceeds Third Quarter 2026 Guidance Raises Full Year 2026 Guidance Third Quarter 2026 Highlights Net Sales of $1.9 billion increased 4%; organic sales increased 5% versus year-ago period GAAP Income…
benzinga.com 10 Industrials Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com DuPont Rolls Out DuPont AmberChrom SIL Silica Gel DuPont (NYSE: DD) today announced the launch of DuPont™ AmberChrom™ SIL silica gel, a new reverse phase silica-based solution designed to support the purification and manufacture of peptide…
- benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Lowers Price Target to $160 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and lowers the price target from $176 to $160.
- benzinga.com Barclays Initiates Coverage On DuPont de Nemours with Overweight Rating, Announces Price Target of $156 Barclays analyst Aleksey Yefremov initiates coverage on DuPont de Nemours (NYSE:DD) with a Overweight rating and announces Price Target of $156.
- benzinga.com JP Morgan Downgrades DuPont de Nemours to Neutral, Lowers Price Target to $145 JP Morgan analyst Chigusa Katoku downgrades DuPont de Nemours (NYSE:DD) from Overweight to Neutral and lowers the price target from $172 to $145.
- benzinga.com Citigroup Maintains Buy on DuPont de Nemours, Lowers Price Target to $162 Citigroup analyst Patrick Cunningham maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $170 to $162.
benzinga.com UBS Maintains Buy on DuPont de Nemours, Lowers Price Target to $172 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $178 to $172.
benzinga.com Why Is Chemours Stock Trading Higher Today? Chemours PFAS settlement lifts shares as the $455 million deal clarifies liabilities, payment timing and future escrow obligations.
benzinga.com Chemours, DuPont De Nemours And Corteva Reach Settlement State Of North Carolina And 11 Local Entities; Overall Settlement Payments Total $455M Over 15 Years, With Chemours' 50% Share Of Payments Of ~$180M On NPV Basis Covered By Existing Accruals The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the- benzinga.com JP Morgan Maintains Overweight on DuPont de Nemours, Raises Price Target to $172 JP Morgan analyst Chigusa Katoku maintains DuPont de Nemours (NYSE:DD) with a Overweight and raises the price target from $171 to $172.
- benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Lowers Price Target to $176 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and lowers the price target from $180 to $176.
- benzinga.com 'California sues DuPont over alleged effort to avoid ‘forever chemicals’ liabilities'- Financial Times https://www.ft.com/content/77f00cf3-f2e6-4dcb-bf0d-1631ca45dd9c?syn-25a6b1a6=1&_gl=1*1lkg4gt*_up*MQ..&gclid=4b5f5274ad6f1d1dc16438006235df49&gclsrc=3p.ds
- benzinga.com UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $178 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $175 to $178.
benzinga.com DuPont Says It Is Exploring M&A Opportunities in Water and Healthcare DuPont Earnings Outlook improves after a Q2 beat, but a narrower sales range and currency headwinds pressure shares.- benzinga.com Conference Call:
DuPont de Nemours Sees Q3 Adj EPS $1.80-$1.90 vs $1.93 Est; Sees Sales $1.835B vs $1.877B Est DuPont de Nemours (NYSE:DD) is looking for Q3 Adj EPS of $1.80-$1.90 vs $1.93 analyst estimate. sees sales of $1.835 billion vs $1.877 billion analyst estimate.
benzinga.com DuPont de Nemours Q2 2026 Earnings Call: Complete Transcript DuPont de Nemours (NYSE:DD) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide…- benzinga.com DuPont de Nemours Raises FY2026 Adj EPS Guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 Est; Narrows FY2026 Sales Guidance from $7.155B-$7.215B to $7.160B-$7.190B vs $7.164B Est DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $7.02-$7.16 to $7.17-$7.32 vs $7.13 analyst estimate. Narrows FY2026 sales outlook from $7.155 billion-$7.215 billion to $7.160…
benzinga.com EXCLUSIVE: Alphabet’s Empire Could Be Worth More In Pieces, Jay Woods Says Spinning off business units for companies can unlock shareholder value. Market expert Jay Woods shares his favorite spinoff potential name.- benzinga.com Morgan Stanley Maintains Equal-Weight on DuPont de Nemours, Raises Price Target to $156 Morgan Stanley analyst Vincent Andrews maintains DuPont de Nemours (NYSE:DD) with a Equal-Weight and raises the price target from $52 to $156.
- benzinga.com Qnity Electronics Stock Trends After Hours: CEO Tells Jim Cramer Company 'Right At The Center' Of Materials Innovation, The 'Hidden Hero' Of AI Era Qnity Electronics shares rose 2.85% after hours as investors reacted to the CEO’s upbeat comments on AI-driven semiconductor demand.
- benzinga.com DuPont de Nemours Affirms FY2026 Adj EPS Guidance of $7.02-$7.16 vs $7.17 Est DuPont de Nemours (NYSE:DD) affirms FY2026 Adj EPS guidance from $7.02-$7.16 to $7.02-$7.16 vs $7.17 analyst estimate..
- benzinga.com RBC Capital Maintains Outperform on DuPont de Nemours, Raises Price Target to $60 RBC Capital analyst Arun Viswanathan maintains DuPont de Nemours (NYSE:DD) with a Outperform and raises the price target from $56 to $60.
- benzinga.com UBS Maintains Buy on DuPont de Nemours, Raises Price Target to $59 UBS analyst Joshua Spector maintains DuPont de Nemours (NYSE:DD) with a Buy and raises the price target from $56 to $59.
benzinga.com DuPont Flexes Pricing Power, Initiates Accelerated Stock Buyback DuPont (NYSE: DD) beats Q1 estimates with $1.68B in sales and 15% EBITDA growth. Shares rose over 7% as the company raises 2026 guidance.
benzinga.com Transcript: DuPont de Nemours Q1 2026 Earnings Conference Call 
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com DuPont de Nemours Sees Q2 Adj EPS $0.59 vs $0.58 Est; Sees Sales $1.800B vs $1.805B Est DuPont de Nemours (NYSE:DD) is looking for Q2 Adj EPS of $0.59 vs $0.58 analyst estimate. sees sales of $1.800 billion vs $1.805 billion analyst estimate.- benzinga.com DuPont de Nemours Raises FY2026 Adj EPS Guidance from $2.25-$2.30 to $2.35-$2.40 vs $2.27 Est; Raises FY2026 Sales Guidance from $7.075B-$7.135B to $7.155B-$7.215B vs $7.097B Est DuPont de Nemours (NYSE:DD) raises FY2026 Adj EPS guidance from $2.25-$2.30 to $2.35-$2.40 vs $2.27 analyst estimate. Raises FY2026 sales outlook from $7.075 billion-$7.135 billion to $7.155…